The @US_FDA is introducing a new resource providing our view of certain established gene-drug interactions that appear in FDA-approved drug labeling and additional gene-drug interactions that are consistent with current labeling and supported by sufficient scientific evidence.pic.twitter.com/z0qsdho1BV

The @US_FDA is introducing a new resource providing our view of certain established gene-drug interactions that appear in FDA-approved drug labeling and additional gene-drug interactions that are consistent with current labeling and supported by sufficient scientific evidence. pic.twitter.com/z0qsdho1BV
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news